Kir3.3 Products

Description

The Kir3.3 (KCNJ9) encodes for a 393 amino acid long, 44 kDA, G-protein activated inward rectifier potassium channel protein that creates heteromultimeric pore-forming complexes. The Kir3.3 gene has been investigated in generalized epilepsy, meniere's disease, pertussis, lung cancer, schizophrenia, and diabetes mellitus. It interacts with the DRD4, KCNJ6, ADRB2, KCNJ3, and DRD2 genes in potassium transporting pathways (inward and outward), G-Beta gamma signaling, neurotransmitter receptor binding and downward transmission in the postsynaptic cell, and ion currents in synaptic transmission.

Bioinformatics

Entrez	3765 Human 16524 Mouse 50599 Rat 116560 Rat
Uniprot	Q92806 Human
Product By Gene ID	3765
Alternate Names	inwardly rectifier K+ channel KIR3.3 GIRK-3 G protein-coupled inward rectifier potassium channel Potassium channel, inwardly rectifying subfamily J member 9 G protein-activated inward rectifier potassium channel 3 Inward rectifier K(+) channel Kir3.3 GIRK3KIR3.3 Kir3.3 potassium inwardly-rectifying channel, subfamily J, member 9

Diseases related to Kir3.3

Discover more about diseases related to Kir3.3.

Diabetes Mellitus
Diabetes Mellitus, Non-insulin-dependent
Dysequilibrium Syndrome
Nervousness
Pain
Epilepsy
Hyperalgesia
Sclerosis
Neurodegenerative Disorders
Idiopathic Generalized Epilepsy
Epilepsy, Generalized
Metabolic Diseases
Substance Withdrawal Syndrome
Globus Hystericus

Pathways for Kir3.3

View related products by pathway and learn more about each of the pathways below.

Localization
Neurogenesis
Transport
Cell Proliferation
Mrna Transcription
Gliogenesis
Brain Development
Synaptic Transmission

PTMs for Kir3.3

Learn more about PTMs related to Kir3.3.

Glycosylation

Bioinformatics Tool for Kir3.3

Discover related pathways, diseases and genes to Kir3.3. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.